Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women

Biological Trace Element Research

Volumn 133, Issue 2, 2010, Pages 136-143

  Aydin, Hasan ^a   Deyneli, Oǧuzhan ^b   Yavuz, Dilek ^b   Gözü, Hülya ^c   Mutlu, Nilgün ^a   Kaygusuz, Işik ^b   Akalm, Sema ^b  

^a YEDITEPE UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c stanbul Kartal Dr Lütfü K rdar State Hospital   (Turkey)

Author keywords

Bone turnover; Magnesium; Postmenopausal osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; MAGNESIUM CITRATE; MAGNESIUM DIASPORAL PASTIL; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; UNCLASSIFIED DRUG; AMINO ACID; BIOLOGICAL MARKER; CITRIC ACID; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; LOOSE FECES; MENOPAUSE; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; ANIMAL; BLOOD; BONE; BONE DENSITY; DIET SUPPLEMENTATION; DRUG EFFECT; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RAT; URINE;

ADMINISTRATION, ORAL; AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CITRIC ACID; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; RATS;

EID: 77950366833     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8416-8     Document Type: Article

References (33)

1. Tranquilli AL, Lucino E, Garzetti GG, Romanini C (1994) Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women. Gynecol Endocrinol 1: 55-58 (Pubitemid 24116835)
2. Reginster JY, Strause L, Deroisy R, Lecart MP, Saltman P, Franchimont P (1989) Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Magnesium 8 (2): 106-109 (Pubitemid 19165861)
3. Steidl L, Ditmar R (1991) Blood magnesium, calcium and zinc in osteoporosis. Acta Univ Palacki Olomuc Fac Med 129: 91-98
4. Ditmar R, Steidl L (1989) The significance of magnesium in orthopedics. Magnesium in osteoporosis. Acta Chir Orthop Traumatol Cech 56 (2): 143-159
5. Cohen L (1988) Recent data on magnesium and osteoporosis. Magnes Res 1-2: 85-87
6. Wallach S (1990) Effects of magnesium on skeletal metabolism. Magnes Trace Elem 9 (1): 1-14
7. Yano K, Heilbrun LK, Wasnich RD, Hankin JH, Vogel JM (1985) The relationship between diet and bone mineral content of multiple skeletal sites in elderly Japanese-American men and women living in Hawaii. Am J Clin Nutr 42: 877-888 (Pubitemid 16225298)
8. Schaafsma A, Pakan I (1999) Short-term effects of a chicken egg shell powder enriched dairy-based product on bone mineral density in persons with osteoporosis or osteopenia. Bratisl Lek Listy 12: 651-656
9. Sojka JE, Weaver JM (1995) Magnesium supplementation and osteoporosis. Nutr Rev 53 (3): 71-74
10. Eisinger J, Clairet D (1993) Effects of silicone, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res 3: 247-249
11. Dimai HP, Porta S, Wirnsberger G, Lindschinger M, Pamperl I, Dobnig H, Wilders-Truschnig M, Lau KH (1998) Daily oral magnesium supplementation suppresses bone turnover in young adult males. J Clin Endocrinol Metab 83 (8): 2742-2748 (Pubitemid 28493770)
12. Doyle L, Flynn A, Cashman K (1999) The effect of magnesium supplementation on biochemical markers of bone metabolism or blood pressure in healthy young adult females. Eur J Clin Nutr 53 (4): 255-261 (Pubitemid 29164255)
13. Toba Y, Kajita Y, Masuyama R, Takada Y, Suzuki K, Aoe S (2000) Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats. J Nutr 130 (2): 216-220 (Pubitemid 30073797)
14. WHO (1994) Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. WHO Technical Report Series, Genova
15. Kress BC, Mizrahi IA (1999) Monitoring antiosteoporotic treatment of postmenopausal women using biochemical markers of bone turnover. Drugs Today (Bare) 35 (3): 181-185 (Pubitemid 29238941)
16. Delmas PD (1993) Biochemical markers of bone turnover. J Bone Miner Res 8 (suppl2): S549-555
17. Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD (2000) Serum estradiol and sex hormone binding globulin and the risk of hip fracture. J Bone Miner Res 15 (9): 1835-1841
18. Eyre DR (1997) Bone biomarkers as a tool in osteoporosis management. Spine 24 (Suppl): S17-S24
19. Overgaard K, Hansen MA, Jensen SB, Christiansen C (1992) Effect of salcatonin given intra-nasally on bone mass and fracture rates in established osteoporosis: a dose-response study. Br Med J 305: 556-561
20. Harris ST, Gertz BJ, Genant HK, Eyre DR, Survill TT, Ventura JN, De Brock J, Ricerco E, Chesnut CH 3rd (1993) The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endocrinol Metab 76 (6): 1399-1406
21. Epstein S, Poser J, McClintock R, Johnston CC Jr, Bryce G, Hui S (1984) Differences in bone GLA protein with age and sex. Lancet 8372: 307-310 (Pubitemid 14185336)
22. Chesnut CH 3rd, Harris ST (1993) Short term effect of alendronate on bone mass and bone remodeling in postmenopausal women. Osteopros Int 3 (Suppl 3): S17-S19
23. Clifford JR, Charles H, Chesnut CH 3rd, Nancy JSM (1997) The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab 82 (6): 1904-1910
24. Rude RK, Gruber HE (2004) Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem 15: 710-716 (Pubitemid 40018113)
25. Rude RK, Gruber HE, We LY, Frausto A, Mills BG (2003) Magnesium deficiency: effect on bone and mineral metabolism in the mouse. Calcif Tissue Int 72: 32-41 (Pubitemid 36918935)
26. Creedon A, Flynn A, Cashman K (1999) The effect of moderately and severely restricted dietary magnesium intakes on bone composition and bone metabolism in the rat. Br J Nutr 82: 63-71 (Pubitemid 29377977)
27. Arnaud CD, Sanchez SD (1990) The role of calcium in osteoporosis. Annu Rev Nutr 10: 397-414
28. Rude RK, Oldham SB, Sharp CF Jr, Singer FR (1978) Parathyroid hormone secretion in magnesium deficiency. J Clin Endocrinol Metab 47: 800-806 (Pubitemid 9036630)
29. Marie PJ, Travers R, Delvin EF (1983) Influence of magnesium supplementation on bone turnover in the normal young mouse. Calcif Tissue Int 35 (6): 755-761 (Pubitemid 14202349)
30. Carpenter TO, Mackowiak SJ, Troiano N, Gundberg CM (1992) Osteocalcin and its message: relationship to bone histology in Mg-deprived rats. Am J Physiol 26: E106-E114
31. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Mills BG (2004) Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha. J Nutr 134 (1): 79-85 (Pubitemid 38057427)
32. Makgoba MW, Datta HK (1992) The critical role of magnesium ions in osteoclast-matrix interaction: implications for divalent cations in the study of osteoclastic adhesion molecules and bone resorption. Eur J Clin Invest 22 (10): 692-696
33. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF (1992) Magnesium deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 110 (2): 169-173